Jpmorgan Chase & Co »

Sagimet Biosciences Inc-a shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.1M 1.1M 5.42
2023-12-31 $19k 3.5k 5.42
2023-09-30 $31k 3.5k 8.80

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a